Search INSP
Inspire Medical Systems, Inc.
NYSE · CIK 1609550
Last close69.97
Daily change-0.81 (-1.14%)
10 Years gain+180.10%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
INSP · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
69.1Momentum
51.0Acceleration
49.9Confidence
91.0Annual Revenue10
Quarterly Revenue36
Annual CFO10
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth22.3 / 25
Quality16.0 / 25
Capital Efficiency9.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics3.3 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 0.8443 percentage points.
Operating leverageOperating margin improved by 0.1995 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 4.5218%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
High SBC · MEDIUMStock based compensation is high relative to revenue or FCF.
Key Metrics
Revenue Growth TTM10.77%OK
Revenue CAGR 3Y30.77%OK
Gross Margin85.45%OK
Operating Margin0.55%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC0.74%OK
Incremental Operating Margin 3Y9.99%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-4.52%OK
SBC / Revenue15.72%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $911.98M | $778.76M | $50.95M | $116.98M | $78.48M | 85.39% | 5.59% | 8.61% | 9.24% | 29.76M |
| 2025 FY Dec 31, 2024 | $802.80M | $679.82M | $36.08M | $130.25M | $91.12M | 84.68% | 4.49% | 11.35% | 18.54% | 30.54M |
| 2025 FY Dec 31, 2023 | $624.80M | $528.22M | -$40.27M | $24.65M | $1.02M | 84.54% | -6.45% | 0.16% | -40.6% | 29.3M |
| 2024 FY Dec 31, 2022 | $407.86M | $341.74M | -$47.59M | $11.57M | $2.47M | 83.79% | -11.67% | 0.61% | -89.86% | 28.07M |
| 2023 FY Dec 31, 2021 | $233.39M | $200.12M | -$39.85M | -$20.12M | -$24.79M | 85.74% | -17.07% | -10.62% | -106.78% | 27.26M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $846.75M | sum latest 4 fiscal quarters Revenue | OK | 0001609550-26-000047, 0001609550-25-000053 |
| Revenue Growth TTM | 10.77% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001609550-26-000047, 0001609550-25-000053 |
| Revenue CAGR 3Y | 30.77% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001609550-26-000016 |
| Revenue CAGR 5Y | 51.21% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001609550-26-000016 |
| Gross Profit CAGR 3Y | 31.59% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001609550-26-000016 |
| Operating Income Growth | 73.03% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001609550-26-000047, 0001609550-25-000053 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 85.45% | Gross Profit / Revenue | OK | 0001609550-26-000047, 0001609550-25-000053 |
| Operating Margin | 0.55% | Operating Income / Revenue | OK | 0001609550-26-000047, 0001609550-25-000053 |
| ROIC | 0.74% | NOPAT / Average Invested Capital | OK | 0001609550-26-000047, 0001609550-25-000053 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001609550-26-000047 |
| Current Ratio | 8.55x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 15.72% | SBC / Revenue | OK | 0001609550-26-000047, 0001609550-25-000053 |
| Revenue per Diluted Share | $29.26 | Revenue / Diluted Shares | OK | 0001609550-26-000047, 0001609550-25-000053 |